M. Scholl

CD62Lhigh Treg cells with superior immunosuppressive properties accumulate within the CNS during remissions of EAE

A. Melms, F. Bischof, C. Lange, 2011, Brain, Behavior, and Immunity.

Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease.

E. Copelan, B. Avalos, L. Lasky, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.

E. Copelan, B. Avalos, J. Klein, 1996, Bone marrow transplantation.

Influence of graft-versus-host disease on outcome following allogeneic transplantation with radiation-free preparative therapy in patients with advanced leukemia.

E. Copelan, B. Avalos, P. Elder, 1996, Bone marrow transplantation.

The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy

M. Scholl, S. Ezzone, S. Penza, 2000, Bone Marrow Transplantation.

Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma

M. Goormastic, M. Kalaycio, B. Bolwell, 2000, Bone Marrow Transplantation.

Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation

M. Scholl, S. Ezzone, S. Penza, 2000, Bone Marrow Transplantation.

Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation

M. Scholl, S. Ezzone, S. Penza, 2001, Bone Marrow Transplantation.

Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation

S. Lemeshow, G. Marcucci, S. Farag, 2004, Bone Marrow Transplantation.

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Adam L. Comer, Robert G. Miller, S. Demeret, 2023, The Lancet Neurology.

Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

U. Ziemann, M. Krumbholz, B. Hemmer, 2020, PloS one.